blog

Why Laboratory Methods and Calculation Formulas Change Free Testosterone Interpretations

Understand why total and free testosterone results can differ, how SHBG and albumin add context, and why testing methods matter.

Why Laboratory Methods and Calculation Formulas Change Free Testosterone Interpretations
Share
PinterestFacebookLinkedInRedditTelegramX (Twitter)
Nov 12, 2026
Testing & Biomarkers

Total testosterone and free testosterone describe different aspects of circulating hormone, making SHBG relevant when clinicians assess whether mismatched results suggest a testosterone deficiency.

This article is for informational purposes only and is not medical advice. Individual testing and treatment decisions belong with a qualified clinician.

Total testosterone

A total testosterone test measures the total concentration of testosterone in the blood. That includes testosterone circulating in protein-bound and unbound forms. Its clinical use is to help assess testosterone status alongside symptoms and other relevant findings.

The word “total” matters. This measurement brings those circulating forms into one result rather than reporting the free portion separately. A total testosterone result therefore answers a different question from a free testosterone result.

The European Association of Urology (EAU) guideline notes that total testosterone values can change in relation to circulating sex hormone-binding globulin, usually shortened to SHBG. This binding protein is part of the context clinicians consider when interpreting the total concentration.

That does not make total testosterone an unhelpful test. The EAU uses it within an assessment that includes clinical findings and appropriate laboratory testing. The important distinction is between using total testosterone as part of that assessment and expecting it to describe every aspect of circulating testosterone by itself.

For readers starting with their main blood-test result, understanding what the total measurement includes provides a useful foundation before considering additional markers.

Free testosterone

Free testosterone refers to testosterone circulating without being bound to proteins. Unlike total testosterone, it describes the unbound portion rather than the combined concentration of bound and unbound hormone. This is why the results can provide different information without necessarily contradicting each other.

According to the EAU, assessing free testosterone can improve diagnostic accuracy in symptomatic men. The guideline particularly highlights older men with obesity. It also recommends measuring SHBG and calculating free testosterone when a condition associated with altered SHBG is present.

Measured or calculated

A free testosterone result may come from a measurement or a calculation. Those routes need to be distinguished when reading a report.

The EAU describes equilibrium dialysis as the most accurate method for measuring free testosterone. It also describes calculation using total testosterone, SHBG and albumin as an alternative. Albumin enters the interpretation here because it is an input to the calculation.

A calculated result uses those inputs within a formula. It is an estimate rather than the same measurement as equilibrium dialysis. Its interpretation therefore depends on the input results and the calculation method used.

The EAU does not recommend direct free-testosterone estimation using available immunoassays. A report labelled “free testosterone” needs more context than its name alone: the method used to obtain that value matters.

This distinction is especially relevant when comparing results from different reports. Before treating the numbers as interchangeable, the useful question is whether they were obtained in the same way. Testostra's explanation of laboratory methods and calculated results provides further context for that discussion.

Where SHBG fits

SHBG binds testosterone and helps explain why the total concentration and the free portion do not always follow the same pattern. The EAU's guidance makes this binding relationship clinically relevant when SHBG is altered. Rather than setting total testosterone against free testosterone, clinicians consider what the binding context adds to both.

Higher SHBG

Higher SHBG may accompany a normal-looking total testosterone result despite a lower free testosterone estimate. In this pattern, looking only at the total result may leave out information that becomes apparent when SHBG and free testosterone are considered.

The EAU lists the following contexts as associated with higher SHBG:

  • Anticonvulsants.
  • Oestrogens or thyroid hormone.
  • Hyperthyroidism.
  • Hepatic disease.
  • Ageing.
  • Smoking.
  • HIV/AIDS.

The clinical value of this list is to guide a discussion about relevant medical history and medicines. It gives a clinician possible context for the laboratory pattern. It does not establish which listed factor accounts for an individual's SHBG result.

The distinction between a result and its explanation matters here. Identifying higher SHBG is one observation; deciding why it is higher requires clinical assessment. The laboratory pattern should lead to a more focused review rather than a conclusion drawn from the list alone.

Lower SHBG

Lower SHBG may accompany a low total testosterone result even when free testosterone is less reduced. Here, the total result and the free result may suggest different degrees of reduction because they describe different aspects of circulating testosterone.

The EAU lists these contexts as associated with lower SHBG:

  • Growth hormone or glucocorticoids.
  • Testosterone or anabolic androgenic steroids.
  • Hypothyroidism.
  • Obesity.
  • Acromegaly or Cushing's disease.
  • Insulin resistance, including type 2 diabetes or metabolic syndrome.
  • Non-alcoholic fatty liver disease.
  • Nephrotic syndrome.

These associations explain why a clinician may consider medical conditions and medication history when reviewing the results. They are not instructions to change a medicine or alter hormone treatment. Any decision about an individual's medicines belongs with the clinician responsible for that care.

Obesity is one relevant example from the guideline's list. For readers trying to understand that particular context, the relationship between body weight and the SHBG pattern is worth considering alongside the rest of the assessment.

Reading them together

The useful comparison is not simply whether total testosterone looks more reassuring than free testosterone. It is whether the measurements form an understandable pattern once SHBG and the testing method are included.

For a calculated free testosterone result, albumin also belongs in that review. It is part of the formula alongside total testosterone and SHBG. Its inclusion supports the estimate; it does not turn the calculation into a separate diagnosis.

This creates a more precise way to discuss a mismatch. Instead of asking which result is “right,” the discussion can address what each result represents and how it was obtained. The total concentration and the free estimate may be answering different questions about the same blood sample.

The EAU's recommendation to add SHBG and calculated free testosterone in relevant conditions follows that approach. The added information serves a specific interpretive purpose rather than replacing the broader assessment.

Evidence boundaries

There are several boundaries to keep in one place. An SHBG-associated pattern does not establish hypogonadism or provide a stand-alone reason for treatment. Symptoms associated with late-onset hypogonadism are also not exclusive to that condition.

The EAU further notes that evidence supporting a free testosterone threshold in altered-SHBG settings is limited. One cutoff should therefore not be presented as a universally decisive answer. The practical response is to combine the laboratory pattern with clinical assessment rather than search for one number that settles every case.

Before treatment

The EAU recommends morning, fasting testosterone testing with a reliable laboratory assay. It also recommends repeating a low result on at least two occasions before starting testosterone therapy. These testing conditions and confirmation steps belong in the assessment before a treatment decision.

When total and free testosterone appear inconsistent, a focused discussion with a qualified clinician can address the following questions:

  • Was SHBG measured, and does the result help explain the pattern?
  • Was free testosterone measured by equilibrium dialysis or calculated?
  • If it was calculated, were total testosterone and albumin included with SHBG?
  • Are there relevant conditions or medicines associated with altered SHBG?
  • Was the testosterone sample taken in the morning and fasting?
  • Does the result require repeat testing under the guideline's approach?

These questions help distinguish a binding-related pattern from an incomplete understanding of the laboratory report. They also keep the discussion focused on the information behind the results rather than on choosing a preferred number.

A useful review brings the method and the medical context together. For example, knowing that a value was calculated clarifies why SHBG and albumin appear alongside it. Knowing that a relevant SHBG-altering condition is present explains why the clinician may give that calculation particular attention.

The treatment implication is a matter of assessment rather than a choice between competing biomarkers. The EAU's position is to combine clinical findings with laboratory evidence. Neither total testosterone nor free testosterone is meant to replace the rest of that process.

The whole picture

Total testosterone describes the overall concentration, free testosterone describes the unbound portion, and SHBG helps clinicians interpret their relationship within the wider clinical picture.

How Testostra helps

Moving from SHBG's binding role to the rest of a hormone report calls for clear biomarker explanations, which Testostra publishes as part of its testosterone coverage. For men trying to connect total testosterone with free testosterone and related markers, that educational context helps make laboratory information easier to follow without directing an individual's care.

Read Resources

Sources

  1. Male Hypogonadism - EAU Guidelines on Sexual and Reproductive …

Continue reading

Distinguishing Functional Hormone Suppression from Gland Disease in Clinical Care
November 17, 2026
TRT & Emerging Research

Distinguishing Functional Hormone Suppression from Gland Disease in Clinical Care

Read Article
Why Clinicians Look Past Single Lab Results to Build a Complete Picture of Patient Health
November 17, 2026
Low Testosterone

Why Clinicians Look Past Single Lab Results to Build a Complete Picture of Patient Health

Read Article
Short-Term Hormone Surges During Exercise and the Evidence on Muscle Growth and Strength
November 17, 2026
Lifestyle & Natural Support

Short-Term Hormone Surges During Exercise and the Evidence on Muscle Growth and Strength

Read Article
Man walking outdoors after exercise in a green urban setting.
GET IN TOUCH

Have a testosterone question or research topic in mind?

Send us a question, research idea or topic suggestion. Reader questions help shape future Testostra content.

Contact Testostra